Prevalence and Association of Dysfunctional Breathing With Nicotine Dependence and Physical Activity Among Young Smokers
Prevalence of Dysfunctional Breathing and Its Association With Nicotine Dependence and Physical Activity Level Among Young Smokers: A Cross-Sectional Study
We will structure the study's summary to provide a clear and accessible overview for patients, families, and healthcare providers. The research will examine young adult cigarette smokers aged 18 to 24 to estimate the prevalence of a dysfunctional breathing-compatible symptom pattern using the Nijmegen Questionnaire. Furthermore, the study will assess how nicotine dependence severity-measured via the Fagerström Test for Nicotine Dependence-and physical activity levels-assessed using the International Physical Activity Questionnaire-relate to this symptom burden. We will recruit participants through social media announcements and conduct face-to-face evaluations at Istinye University. The project will employ hierarchical linear and binary logistic regression models, adjusting for age, sex, and body mass index, to determine independent predictors of dysfunctional breathing. Ultimately, the findings will provide valuable insights into the combined impacts of smoking severity and physical activity on respiratory health in young adults.
Panoramica dello studio
Stato
Intervento / Trattamento
Tipo di studio
Iscrizione (Stimato)
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Metodo di campionamento
Popolazione di studio
The study population will consist of young adult cigarette smokers aged 18 to 24 recruited through social media announcements, who will undergo face-to-face evaluation and eligibility assessments at a single center.
Descrizione
Inclusion Criteria:
- Being between 18 and 24 years of age.
- Reporting current cigarette smoking (daily or occasionally) at the time of assessment
Exclusion Criteria:
- Having a diagnosed personality disorder.
- Having a substance use disorder.
- Engaging in regular meditation or breathing exercises.
- Having a chronic cardiovascular or pulmonary disease.
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Modelli osservazionali: OTHER
- Prospettive temporali: CROSS_SECTIONAL
Coorti e interventi
Gruppo / Coorte |
Intervento / Trattamento |
|---|---|
|
Young adult cigarette smokers.
|
This study will not involve any experimental medical treatment or intervention. It will be an observational evaluation where participants will complete self-report instruments, including the Fagerström Test for Nicotine Dependence, the International Physical Activity Questionnaire, and the Nijmegen Questionnaire, along with a sociodemographic form during a single face-to-face session. |
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Fagerström Test for Nicotine Dependence
Lasso di tempo: Measured once during the single face-to-face evaluation session
|
his instrument will assess the severity of nicotine dependence through six items evaluating daily cigarette consumption and smoking patterns. |
Measured once during the single face-to-face evaluation session
|
|
Nijmegen Questionnaire
Lasso di tempo: Measured once during the single face-to-face evaluation session.
|
This questionnaire will assess the symptom burden of respiratory, neurovegetative, and neuromuscular features to identify a dysfunctional breathing-compatible symptom pattern. |
Measured once during the single face-to-face evaluation session.
|
|
International Physical Activity Questionnaire Short Form
Lasso di tempo: Measured once during the single face-to-face evaluation session.
|
This tool will evaluate the participant's physical activity levels over the previous week by recording the duration and frequency of walking and physical activities. |
Measured once during the single face-to-face evaluation session.
|
Collaboratori e investigatori
Sponsor
Studiare le date dei record
Studia le date principali
Inizio studio (Stimato)
Completamento primario (Stimato)
Completamento dello studio (Stimato)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Effettivo)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Parole chiave
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
- 125
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .